• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Healthpeak Properties Reports Second Quarter 2024 Results and Declares Quarterly Cash Dividend on Common Stock

    7/25/24 4:15:00 PM ET
    $DOC
    Real Estate Investment Trusts
    Real Estate
    Get the next $DOC alert in real time by email

    Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the second quarter ended June 30, 2024.

    SECOND QUARTER 2024 FINANCIAL PERFORMANCE AND RECENT HIGHLIGHTS

    • Net income of $0.21 per share, Nareit FFO of $0.44 per share, FFO as Adjusted of $0.45 per share, AFFO of $0.39 per share, and Total Merger-Combined Same-Store Cash (Adjusted) NOI growth of 4.5%
    • Increased full year 2024 diluted earnings guidance to a range of $0.27 – $0.31 per share; increased the midpoint of each 2024 FFO as Adjusted and AFFO guidance by +$0.01 per share, and increased Total Merger-Combined Same-Store Cash (Adjusted) NOI growth guidance by 25 basis points at the midpoint
    • Closed on $853 million of outpatient medical sales at a blended 6.8% trailing cash capitalization rate during the second quarter and through July 25, 2024
      • $1.2 billion of year-to-date dispositions at a blended trailing cash capitalization rate of approximately 6.5%
    • Repurchased 4.6 million shares at a weighted average share price of $19.09 for an aggregate total of $88 million during the second quarter and through July 25, 2024
      • Year-to-date, Healthpeak has repurchased 10.5 million shares at a weighted average share price of $17.98 for $188 million
    • Second quarter new and renewal lease executions totaled 1.7 million square feet:
      • Outpatient Medical new and renewal lease executions totaled 905,000 square feet with a positive 4.7% rent mark-to-market on renewals
      • Lab new and renewal lease executions totaled 797,000 square feet with a positive 6.0% rent mark-to-market on renewals
        • Executed an additional 180,000 square feet lab leases in July 2024
        • Lab leasing pipeline includes 620,000 square feet of signed letters of intent ("LOI") including LOIs at marquee campuses including Gateway at Directors Science Park, Vantage, and Portside
    • In July 2024, executed an early renewal with CommonSpirit Health ("CommonSpirit"), increasing the weighted average lease maturity from July 2027 to December 2035 with a positive rent mark-to-market and 3% annual escalators
    • Added two outpatient medical developments with total expected costs of $53 million with 84% pre-leasing, and mid-7% stabilized yields
    • Net Debt to Adjusted EBITDAre was 5.2x for the quarter ended June 30, 2024
    • On July 24, 2024, Healthpeak's Board of Directors declared a quarterly common stock cash dividend of $0.30 per share to be paid on August 16, 2024, to stockholders of record as of the close of business on August 5, 2024
    • Published 13th annual Corporate Impact Report detailing Healthpeak's comprehensive approach to corporate responsibility and sustainability

    SECOND QUARTER COMPARISON

     

    Three Months Ended

    June 30, 2024

     

    Three Months Ended

    June 30, 2023

    (in thousands, except per share amounts)

    Amount

     

    Per Share

     

    Amount

     

    Per Share

    Net income, diluted

    $

    145,904

     

    $

    0.21

     

    $

    51,750

     

    $

    0.09

    Nareit FFO, diluted

     

    318,610

     

     

     

    0.44

     

     

     

    247,754

     

     

     

    0.45

     

    FFO as Adjusted, diluted

     

    320,220

     

     

     

    0.45

     

     

     

    251,540

     

     

     

    0.45

     

    AFFO, diluted

     

    276,947

     

     

     

    0.39

     

     

     

    223,197

     

     

     

    0.40

     

    YEAR TO DATE COMPARISON

     

    Six Months Ended

    June 30, 2024

     

    Six Months Ended

    June 30, 2023

    (in thousands, except per share amounts)

    Amount

     

    Per Share

     

    Amount

     

    Per Share

    Net income, diluted

    $

    152,345

     

    $

    0.23

     

    $

    169,449

     

    $

    0.31

    Nareit FFO, diluted

     

    479,906

     

     

     

    0.72

     

     

     

    478,200

     

     

     

    0.86

     

    FFO as Adjusted, diluted

     

    597,879

     

     

     

    0.90

     

     

     

    483,421

     

     

     

    0.87

     

    AFFO, diluted

     

    524,599

     

     

     

    0.79

     

     

     

    433,195

     

     

     

    0.78

     

    Nareit FFO, FFO as Adjusted, AFFO, Total Merger-Combined Same-Store Cash (Adjusted) NOI, and Net Debt to Adjusted EBITDAre are supplemental non-GAAP financial measures that we believe are useful in evaluating the operating performance and financial position of real estate investment trusts (see the "Funds From Operations" and "Adjusted Funds From Operations" sections of this release for additional information). See "June 30, 2024 Discussion and Reconciliation of Non-GAAP Financial Measures" for definitions, discussions of their uses and inherent limitations, and reconciliations to the most directly comparable financial measures calculated and presented in accordance with GAAP in the Investor Relations section of our website at http://ir.healthpeak.com/quarterly-results.

    MERGER-COMBINED SAME-STORE ("SS") OPERATING SUMMARY

    The table below outlines the year-over-year three-month and year-to-date Merger-Combined SS Cash (Adjusted) NOI growth.

    Year-Over-Year Total Merger-Combined SS Cash (Adjusted) NOI Growth

     

    Three Month

     

    Year-To-Date

     

    SS Growth %

    % of SS

     

    SS Growth %

    % of SS

    Outpatient Medical

    3.1%

    56.1%

     

    2.7%

    56.2%

    Lab

    3.0%

    34.4%

     

    2.9%

    34.3%

    CCRC

    20.5%

    9.5%

     

    23.4%

    9.5%

    Total Merger-Combined SS Cash (Adjusted) NOI

    4.5%

    100.0%

     

    4.4%

    100.0%

    PHYSICIANS REALTY TRUST MERGER INTEGRATION

    In July, Healthpeak internalized outpatient property management in two additional markets. To date, the company has completed internalization of property management in 12 markets covering more than 17 million square feet, with two additional markets expected to be internalized by year-end 2024.

    Healthpeak anticipates achieving at least $45 million of merger-related synergies during 2024.

    DISPOSITION UPDATE

    During the second quarter and through July 25, 2024, Healthpeak closed on $853 million of outpatient medical sales at blended trailing cash capitalization rate of 6.8%. Healthpeak is also under contract to sell two additional outpatient medical buildings for $23 million.

    Closed and pending dispositions total 3.3 million square feet across 72 assets with geographical concentration in Ohio (23% of total square footage), Nebraska (16%), North Dakota (12%), and upstate New York (11%). Pro forma for the sales, CommonSpirit leases approximately 2 million square feet from Healthpeak and represents 3% of annualized base rent ("ABR"), down from 2.9 million square feet and 4% of ABR prior to the dispositions.

    Disposition Portfolios and Remaining Healthpeak Outpatient Medical Portfolio Summary

     

    Outpatient Medical Portfolios(1)

     

    Dispositions

    Remaining Healthpeak

    Number of properties

    72

    507

    Total square feet

    3.3 million

    36 million

    Average building size (square feet)

    45,000

    72,000

    Average building age(2)

    28 years

    23 years

    Percent on-campus or affiliated

    88%

    96%

    Percent leased to health systems

    57%

    68%

    Population density(3)

    2,300

    3,600

    Population growth(3)

    2.4%

    3.3%

    (1)

    Dispositions include two properties placed under contract in July, with the sale expected to close during the second half of 2024. Remaining Healthpeak excludes unconsolidated joint ventures.

    (2)

    Age as of 6/30/2024 and weighted by total square footage.

    (3)

    Current 5-mile population density is shown as people per square mile. 5-mile population growth from 2023 to 2028, weighted by leasable area. Demographic data from Placer.ai.

    In conjunction with one of the portfolio sales, Healthpeak expects to provide that buyer with a total of $418 million of secured seller financing, representing a 60% loan to value on the acquired portfolio. The secured seller financing carries a two-year initial term and two, 12-month extension options. The interest rate on the secured seller financing is fixed at 6.0% for the initial term and increases to 6.5% during the optional extension periods. As of July 25, 2024, Healthpeak has funded approximately $405 million and expects to fund the balance of the secured seller financing following the sale of two currently under contract properties.

    Year-to-date, Healthpeak has closed on approximately $1.2 billion of asset sales at a blended trailing cash capitalization rate of approximately 6.5%.

    COMMONSPIRIT EARLY LEASE RENEWAL

    In July, we executed an early lease renewal for a minimum of 90% of CommonSpirit's approximately 2 million rentable square foot portfolio with Healthpeak.

    The renewal provides for an average of 8+ years of additional term following the original expiration dates of the current leases, which are primarily in 2026, 2027, and 2028 ("Original Expiration"), extending CommonSpirit's pro forma weighted average lease term from July 2027 to December 2035. Following the Original Expiration, CommonSpirit's base rent will increase and annual contractual lease escalators will increase from 2.5% to 3.0%. Beginning on the Original Expiration, CommonSpirit has the right to renew some or all of the remaining 10% of its rentable square feet on similar terms including an increase in base rent and 3.0% annual contractual lease escalators.

    SHARE REPURCHASE ACTIVITY

    Healthpeak repurchased 4.6 million shares at a weighted average share price of $19.09 for an aggregate total of $88 million from the beginning of the second quarter through and including July 25, 2024.

    Year-to-date 2024, Healthpeak has repurchased 10.5 million shares at a weighted average share price of $17.98 for $188 million.

    In July 2024, the Board replaced Healthpeak's existing share repurchase authorization with a new $500 million share repurchase authorization effective through July 2026. The shares may be repurchased through various methods, including in the open market at Healthpeak's discretion and subject to market conditions, regulatory requirements, and other customary conditions.

    DEVELOPMENT UPDATES

    NEW OUTPATIENT MEDICAL DEVELOPMENTS

    During the second quarter, Healthpeak added two outpatient developments to its program with HCA. Total development costs are $53 million with stabilized cash yields in the mid-7% range.

    • Brandon Medical Center: $27 million, 72,000 square foot Class A outpatient medical building located on HCA's Brandon Regional Hospital campus, a 479-bed acute care hospital in Tampa, Florida. HCA affiliates have pre-leased 70% of the development for graduate medical education and clinical outpatient services.
    • Pooler Medical Center: $26 million, 63,000 square foot Class A build-to-suit outpatient medical building in Savannah, Georgia. Affiliates of HCA will lease 100% of the development for nurse education and clinical outpatient services.



      The Pooler development is Healthpeak's second HCA development in the Savannah market. The previously announced 70,000 square foot development on HCA's Memorial Health University Medical Center began construction in 2022 and is expected to deliver during the second half of 2024.

    VANTAGE LAB CAMPUS

    During the second quarter 2024, Healthpeak placed 23,000 square feet of fully-occupied space into service at Vantage in South San Francisco, California, bringing occupancy at the campus to 52%. The remaining 166,000 square feet at the campus is under construction with an expected initial occupancy in mid-2025.

    BUFORD OUTPATIENT BUILDING

    During the second quarter 2024, Healthpeak placed Northside Medical Buford into service. The $38 million, 97,000 square foot outpatient development is located in Buford, a northern suburb of Atlanta. The building is 100% leased and anchored by Northside Hospital, a leading health system in Atlanta. The building includes an orthopedic-anchored ambulatory surgery center, and other outpatient services including cardiology, medical oncology, imaging, primary care, and urgent care. Healthpeak owns the building in a 57% / 43% joint venture with Northside Hospital affiliated physicians. Healthpeak holds development rights to an additional outpatient building on an adjacent land parcel.

    CORPORATE RESPONSIBILITY AND SUSTAINABILITY

    Recent sustainability and corporate impact achievements include:

    • Published 13th annual Corporate Impact Report, covering environmental, social, and governance initiatives and performance and community and stakeholder impact
    • Reported 36% cumulative green building certification in 2023 throughout our portfolio, including 6.4 million square feet of LEED-certified space
    • Named a constituent in the FTSE4Good Index for the 13th consecutive year
    • Committed to the United Nations ("UN") Women's Empowerment Principles
    • Aligned our human rights policy with the UN Guiding Principles on Business and Human Rights and the UN Universal Declaration of Human Rights

    To learn more about Healthpeak's commitment to responsible business, please visit www.healthpeak.com/corporate-impact.

    DIVIDEND

    On July 24, 2024, Healthpeak's Board declared a quarterly common stock cash dividend of $0.30 per share to be paid on August 16, 2024, to stockholders of record as of the close of business on August 5, 2024.

    2024 GUIDANCE

    We are updating the following guidance ranges for full year 2024:

    • Diluted earnings per common share from $0.16 – $0.20 to $0.27 – $0.31
    • Diluted Nareit FFO per share from $1.56 – $1.60 to $1.59 – $1.63
    • Diluted FFO as Adjusted per share from $1.76 – $1.80 to $1.77 – $1.81
    • Diluted AFFO per share from $1.53 – $1.57 to $1.54 – $1.58
    • Total Merger-Combined Same-Store Cash (Adjusted) NOI growth from 2.50% – 4.00% to 2.75% – 4.25%

    These estimates are based on our view of existing market conditions, transaction timing, and other assumptions for the year ending December 31, 2024. For additional details and assumptions, please see page 13 in our corresponding Supplemental Report and the Discussion and Reconciliation of Non-GAAP Financial Measures, both of which are available in the Investor Relations section of our website at http://ir.healthpeak.com.

    CONFERENCE CALL INFORMATION

    Healthpeak has scheduled a conference call and webcast for Friday, July 26, 2024, at 8:00 a.m. Mountain Time.

    The conference call can be accessed in the following ways:

    • Healthpeak's website: https://ir.healthpeak.com/news-events
    • Webcast: https://events.q4inc.com/attendee/861116449. Joining via webcast is recommended for those who will not be asking questions.
    • Telephone: The participant dial-in number is (800) 715-9871.

    An archive of the webcast will be available on Healthpeak's website through July 25, 2025, and a telephonic replay can be accessed through August 2, 2024, by dialing (800) 770-2030 and entering conference ID number 95156.

    ABOUT HEALTHPEAK

    Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates and develops high-quality real estate focused on healthcare discovery and delivery.

    FORWARD-LOOKING STATEMENTS

    Statements contained in this release that are not historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among other things, statements regarding our and our officers' intent, belief or expectation as identified by the use of words such as "may," "will," "project," "expect," "believe," "intend," "anticipate," "seek," "target," "forecast," "plan," "potential," "estimate," "could," "would," "should" and other comparable and derivative terms or the negatives thereof. Examples of forward-looking statements include, among other things: (i) statements regarding timing, outcomes and other details relating to current, pending or contemplated acquisitions, dispositions, developments, redevelopments, joint venture transactions, leasing activity and commitments, financing activities, or other transactions discussed in this release, including statements regarding our anticipated synergies from our merger with Physicians Realty Trust; (ii) the payment of a quarterly cash dividend; and (iii) the information presented under the heading "2024 Guidance." Pending acquisitions, dispositions, joint venture transactions, leasing activity, and financing activity, including those subject to binding agreements, remain subject to closing conditions and may not be completed within the anticipated timeframes or at all. Forward-looking statements reflect our current expectations and views about future events and are subject to risks and uncertainties that could significantly affect our future financial condition and results of operations. While forward-looking statements reflect our good faith belief and assumptions we believe to be reasonable based upon current information, we can give no assurance that our expectations or forecasts will be attained. Further, we cannot guarantee the accuracy of any such forward-looking statement contained in this release, and such forward-looking statements are subject to known and unknown risks and uncertainties that are difficult to predict. These risks and uncertainties include, but are not limited to: macroeconomic trends, including inflation, interest rates, construction and labor costs, and unemployment; risks associated with our merger with Physicians Realty Trust (the "Merger"), including, but not limited to, our ability to integrate the operations of the Company and Physicians Realty Trust successfully and realize the anticipated synergies and other benefits of the Merger or do so within the anticipated time frame; changes within the industries in which we operate; significant regulation, funding requirements, and uncertainty faced by our lab tenants; factors adversely affecting our tenants', operators', or borrowers' ability to meet their financial and other contractual obligations to us; the insolvency or bankruptcy of one or more of our major tenants, operators, or borrowers; our concentration of real estate investments in the healthcare property sector, which makes us more vulnerable to a downturn in that specific sector than if we invested across multiple sectors; the illiquidity of real estate investments; our ability to identify and secure new or replacement tenants and operators; our property development, redevelopment, and tenant improvement risks, including project abandonments, project delays, and lower profits than expected; the ability of the hospitals on whose campuses our outpatient medical buildings are located and their affiliated healthcare systems to remain competitive or financially viable; our ability to develop, maintain, or expand hospital and health system client relationships; operational risks associated with third-party management contracts, including the additional regulation and liabilities of our properties operated through structures permitted by the Housing and Economic Recovery Act of 2008, which includes most of the provisions previously proposed in the REIT Investment Diversification and Empowerment Act of 2007 (commonly referred to as "RIDEA"); economic conditions, natural disasters, weather, and other conditions that negatively affect geographic areas where we have concentrated investments; uninsured or underinsured losses, which could result in significant losses and/or performance declines by us or our tenants and operators; our use of joint ventures that may limit our returns on and our flexibility with jointly owned investments; our use of fixed rent escalators, contingent rent provisions, and/or rent escalators based on the Consumer Price Index; competition for suitable healthcare properties to grow our investment portfolio; our ability to foreclose or exercise rights on collateral securing our real estate-related loans; any requirement that we recognize reserves, allowances, credit losses, or impairment charges; investment of substantial resources and time in transactions that are not consummated; our ability to successfully integrate or operate acquisitions; the potential impact on us and our tenants, operators, and borrowers from litigation matters, including rising liability and insurance costs; environmental compliance costs and liabilities associated with our real estate investments; our ability to satisfy environmental, social and governance and sustainability commitments and requirements, as well as stakeholder expectations; epidemics, pandemics, or other infectious diseases, including the coronavirus disease (Covid), and health and safety measures intended to reduce their spread; human capital risks, including the loss or limited availability of our key personnel; our reliance on information technology systems and any material failure, inadequacy, interruption, or security failure of that technology; volatility, disruption, or uncertainty in the financial markets; increased borrowing costs, including due to rising interest rates; cash available for distribution to stockholders and our ability to make dividend distributions at expected levels; the availability of external capital on acceptable terms or at all, including due to rising interest rates, changes in our credit ratings and the value of our common stock, bank failures or other events affecting financial institutions and other factors; our ability to manage our indebtedness level and covenants in and changes to the terms of such indebtedness; the failure of our tenants, operators, and borrowers to comply with federal, state, and local laws and regulations, including resident health and safety requirements, as well as licensure, certification, and inspection requirements; required regulatory approvals to transfer our senior housing properties; compliance with the Americans with Disabilities Act and fire, safety, and other regulations; laws or regulations prohibiting eviction of our tenants; the requirements of, or changes to, governmental reimbursement programs such as Medicare or Medicaid; legislation to address federal government operations and administrative decisions affecting the Centers for Medicare and Medicaid Services; our participation in the Coronavirus, Aid, Relief and Economic Security Act Provider Relief Fund and other Covid-related stimulus and relief programs; our ability to maintain our qualification as a real estate investment trust ("REIT"); our taxable REIT subsidiaries being subject to corporate level tax; tax imposed on any net income from "prohibited transactions"; changes to U.S. federal income tax laws, and potential deferred and contingent tax liabilities from corporate acquisitions; calculating non-REIT tax earnings and profits distributions; ownership limits in our charter that restrict ownership in our stock; provisions of Maryland law and our charter that could prevent a transaction that may otherwise be in the interest of our stockholders; conflicts of interest between the interests of our stockholders and the interests of holders of Healthpeak OP, LLC ("Healthpeak OP") common units; provisions in the operating agreement of Healthpeak OP and other agreements that may delay or prevent unsolicited acquisitions and other transactions; our status as a holding company of Healthpeak OP; and other risks and uncertainties described from time to time in our Securities and Exchange Commission filings.

    Moreover, other risks and uncertainties of which we are not currently aware may also affect our forward-looking statements, and may cause actual results and the timing of events to differ materially from those anticipated. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements, even if they are subsequently made available by us on our website or otherwise. We do not undertake any obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made.

    Healthpeak Properties, Inc.

    Consolidated Balance Sheets

    In thousands, except share and per share data

     

     

    June 30,

    2024

     

    December 31,

    2023

    Assets

     

     

     

    Real estate:

     

     

     

    Buildings and improvements

    $

    16,448,690

     

     

    $

    13,329,464

     

    Development costs and construction in progress

     

    739,318

     

     

     

    643,217

     

    Land and improvements

     

    3,005,974

     

     

     

    2,647,633

     

    Accumulated depreciation and amortization

     

    (3,796,108

    )

     

     

    (3,591,951

    )

    Net real estate

     

    16,397,874

     

     

     

    13,028,363

     

    Loans receivable, net of reserves of $9,143 and $2,830

     

    275,478

     

     

     

    218,450

     

    Investments in and advances to unconsolidated joint ventures

     

    927,204

     

     

     

    782,853

     

    Accounts receivable, net of allowance of $2,751 and $2,282

     

    59,658

     

     

     

    55,820

     

    Cash and cash equivalents

     

    106,886

     

     

     

    117,635

     

    Restricted cash

     

    52,409

     

     

     

    51,388

     

    Intangible assets, net

     

    1,076,087

     

     

     

    314,156

     

    Assets held for sale, net

     

    —

     

     

     

    117,986

     

    Right-of-use asset, net

     

    440,558

     

     

     

    240,155

     

    Other assets, net

     

    843,554

     

     

     

    772,044

     

    Total assets

    $

    20,179,708

     

     

    $

    15,698,850

     

     

     

     

     

    Liabilities and Equity

     

     

     

    Bank line of credit and commercial paper

    $

    25,000

     

     

    $

    720,000

     

    Term loans

     

    1,645,456

     

     

     

    496,824

     

    Senior unsecured notes

     

    6,551,155

     

     

     

    5,403,378

     

    Mortgage debt

     

    381,416

     

     

     

    256,097

     

    Intangible liabilities, net

     

    227,370

     

     

     

    127,380

     

    Liabilities related to assets held for sale, net

     

    —

     

     

     

    729

     

    Lease liability

     

    313,469

     

     

     

    206,743

     

    Accounts payable, accrued liabilities, and other liabilities

     

    709,219

     

     

     

    657,196

     

    Deferred revenue

     

    907,852

     

     

     

    905,633

     

    Total liabilities

     

    10,760,937

     

     

     

    8,773,980

     

     

     

     

     

    Commitments and contingencies

     

     

     

     

     

     

     

    Redeemable noncontrolling interests

     

    1,433

     

     

     

    48,828

     

     

     

     

     

    Common stock, $1.00 par value: 1,500,000,000 and 750,000,000 shares authorized; 700,316,807 and 547,156,311 shares issued and outstanding

     

    700,317

     

     

     

    547,156

     

    Additional paid-in capital

     

    12,859,567

     

     

     

    10,405,780

     

    Cumulative dividends in excess of earnings

     

    (4,844,683

    )

     

     

    (4,621,861

    )

    Accumulated other comprehensive income (loss)

     

    42,297

     

     

     

    19,371

     

    Total stockholders' equity

     

    8,757,498

     

     

     

    6,350,446

     

     

     

     

     

    Joint venture partners

     

    324,681

     

     

     

    310,998

     

    Non-managing member unitholders

     

    335,159

     

     

     

    214,598

     

    Total noncontrolling interests

     

    659,840

     

     

     

    525,596

     

     

     

     

     

    Total equity

     

    9,417,338

     

     

     

    6,876,042

     

     

     

     

     

    Total liabilities and equity

    $

    20,179,708

     

     

    $

    15,698,850

     

    Healthpeak Properties, Inc.

    Consolidated Statements of Operations

    In thousands, except per share data

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

    2024

     

    2023

     

    2024

     

    2023

    Revenues:

     

     

     

     

     

    Rental and related revenues

    $

    546,781

     

     

    $

    409,967

     

     

    $

    1,008,814

     

     

    $

    802,398

     

    Resident fees and services

     

    140,891

     

     

     

    130,184

     

     

     

    279,667

     

     

     

    257,268

     

    Interest income and other

     

    7,832

     

     

     

    5,279

     

     

     

    13,583

     

     

     

    11,442

     

    Total revenues

     

    695,504

     

     

     

    545,430

     

     

     

    1,302,064

     

     

     

    1,071,108

     

     

     

     

     

     

     

     

     

    Costs and expenses:

     

     

     

     

     

     

     

    Interest expense

     

    74,910

     

     

     

    49,074

     

     

     

    135,817

     

     

     

    97,037

     

    Depreciation and amortization

     

    283,498

     

     

     

    197,573

     

     

     

    502,717

     

     

     

    376,798

     

    Operating

     

    273,827

     

     

     

    221,837

     

     

     

    517,556

     

     

     

    444,925

     

    General and administrative

     

    26,718

     

     

     

    25,936

     

     

     

    50,017

     

     

     

    50,483

     

    Transaction and merger-related costs

     

    7,759

     

     

     

    637

     

     

     

    114,979

     

     

     

    3,062

     

    Impairments and loan loss reserves (recoveries), net

     

    (553

    )

     

     

    2,607

     

     

     

    10,905

     

     

     

    394

     

    Total costs and expenses

     

    666,159

     

     

     

    497,664

     

     

     

    1,331,991

     

     

     

    972,699

     

    Other income (expense):

     

     

     

     

     

     

     

    Gain (loss) on sales of real estate, net

     

    122,044

     

     

     

    4,885

     

     

     

    125,299

     

     

     

    86,463

     

    Other income (expense), net

     

    4,004

     

     

     

    1,955

     

     

     

    82,520

     

     

     

    2,727

     

    Total other income (expense), net

     

    126,048

     

     

     

    6,840

     

     

     

    207,819

     

     

     

    89,190

     

     

     

     

     

     

     

     

     

    Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures

     

    155,393

     

     

     

    54,606

     

     

     

    177,892

     

     

     

    187,599

     

    Income tax benefit (expense)

     

    (2,728

    )

     

     

    (1,136

    )

     

     

    (16,426

    )

     

     

    (1,438

    )

    Equity income (loss) from unconsolidated joint ventures

     

    51

     

     

     

    2,729

     

     

     

    2,427

     

     

     

    4,545

     

    Net income (loss)

     

    152,716

     

     

     

    56,199

     

     

     

    163,893

     

     

     

    190,706

     

    Noncontrolling interests' share in earnings

     

    (6,669

    )

     

     

    (4,300

    )

     

     

    (11,170

    )

     

     

    (19,855

    )

    Net income (loss) attributable to Healthpeak Properties, Inc.

     

    146,047

     

     

     

    51,899

     

     

     

    152,723

     

     

     

    170,851

     

    Participating securities' share in earnings

     

    (214

    )

     

     

    (149

    )

     

     

    (414

    )

     

     

    (1,402

    )

    Net income (loss) applicable to common shares

    $

    145,833

     

     

    $

    51,750

     

     

    $

    152,309

     

     

    $

    169,449

     

     

     

     

     

     

     

     

     

    Earnings (loss) per common share:

     

     

     

     

     

     

     

    Basic

    $

    0.21

     

     

    $

    0.09

     

     

    $

    0.23

     

     

    $

    0.31

     

    Diluted

    $

    0.21

     

     

    $

    0.09

     

     

    $

    0.23

     

     

    $

    0.31

     

    Weighted average shares outstanding:

     

     

     

     

     

     

     

    Basic

     

    702,382

     

     

     

    547,026

     

     

     

    651,642

     

     

     

    546,936

     

    Diluted

     

    703,268

     

     

     

    547,294

     

     

     

    652,113

     

     

     

    547,204

     

    Healthpeak Properties, Inc.

    Funds From Operations

    In thousands, except per share data

     

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2024

     

    2023

     

    2024

     

    2023

    Net income (loss) applicable to common shares

     

    $

    145,833

     

     

    $

    51,750

     

     

    $

    152,309

     

     

    $

    169,449

     

    Real estate related depreciation and amortization

     

     

    283,498

     

     

     

    197,573

     

     

     

    502,717

     

     

     

    376,798

     

    Healthpeak's share of real estate related depreciation and amortization from unconsolidated joint ventures

     

     

    11,621

     

     

     

    5,893

     

     

     

    20,393

     

     

     

    11,887

     

    Noncontrolling interests' share of real estate related depreciation and amortization

     

     

    (4,732

    )

     

     

    (4,685

    )

     

     

    (9,174

    )

     

     

    (9,470

    )

    Loss (gain) on sales of depreciable real estate, net

     

     

    (122,044

    )

     

     

    (4,885

    )

     

     

    (125,299

    )

     

     

    (86,463

    )

    Noncontrolling interests' share of gain (loss) on sales of depreciable real estate, net

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    11,546

     

    Loss (gain) upon change of control, net(1)

     

     

    (198

    )

     

     

    (234

    )

     

     

    (77,978

    )

     

     

    (234

    )

    Taxes associated with real estate dispositions(2)

     

     

    49

     

     

     

    —

     

     

     

    11,657

     

     

     

    —

     

    Nareit FFO applicable to common shares

     

     

    314,027

     

     

     

    245,412

     

     

     

    474,625

     

     

     

    473,513

     

    Distributions on dilutive convertible units and other

     

     

    4,583

     

     

     

    2,342

     

     

     

    5,281

     

     

     

    4,687

     

    Diluted Nareit FFO applicable to common shares

     

    $

    318,610

     

     

    $

    247,754

     

     

    $

    479,906

     

     

    $

    478,200

     

    Diluted Nareit FFO per common share

     

    $

    0.44

     

     

    $

    0.45

     

     

    $

    0.72

     

     

    $

    0.86

     

    Weighted average shares outstanding - Diluted Nareit FFO

     

     

    717,797

     

     

     

    554,584

     

     

     

    661,999

     

     

     

    554,494

     

    Impact of adjustments to Nareit FFO:

     

     

     

     

     

     

     

     

    Transaction and merger-related items(3)

     

    $

    3,369

     

     

    $

    581

     

     

    $

    106,198

     

     

    $

    2,944

     

    Other impairments (recoveries) and other losses (gains), net(4)

     

     

    (553

    )

     

     

    2,432

     

     

     

    11,300

     

     

     

    1,159

     

    Restructuring and severance-related charges

     

     

    —

     

     

     

    1,368

     

     

     

    —

     

     

     

    1,368

     

    Casualty-related charges (recoveries), net(5)

     

     

    (1,204

    )

     

     

    (591

    )

     

     

    (1,204

    )

     

     

    (243

    )

    Total adjustments

     

     

    1,612

     

     

     

    3,790

     

     

     

    116,294

     

     

     

    5,228

     

    FFO as Adjusted applicable to common shares

     

     

    315,639

     

     

     

    249,202

     

     

     

    590,919

     

     

     

    478,741

     

    Distributions on dilutive convertible units and other

     

     

    4,581

     

     

     

    2,338

     

     

     

    6,960

     

     

     

    4,680

     

    Diluted FFO as Adjusted applicable to common shares

     

    $

    320,220

     

     

    $

    251,540

     

     

    $

    597,879

     

     

    $

    483,421

     

    Diluted FFO as Adjusted per common share

     

    $

    0.45

     

     

    $

    0.45

     

     

    $

    0.90

     

     

    $

    0.87

     

    Weighted average shares outstanding - Diluted FFO as Adjusted

     

     

    717,797

     

     

     

    554,584

     

     

     

    664,325

     

     

     

    554,494

     

    _______________________________________

    (1)

    The six months ended June 30, 2024 includes a gain upon change of control related to the sale of a 65% interest in two lab buildings in San Diego, California. The gain upon change of control is included in other income (expense), net in the Consolidated Statements of Operations.

    (2)

    The six months ended June 30, 2024 includes non-cash income tax expense related to the sale of a 65% interest in two lab buildings in San Diego, California.

    (3)

    The three and six months ended June 30, 2024 includes costs related to the Merger, which are primarily comprised of advisory, legal, accounting, tax, post-combination severance and stock compensation expense, and other costs of combining operations with Physicians Realty Trust that were incurred during the period. These costs were partially offset by termination fee income of $4 million and $9 million for the three and six months ended June 30, 2024, respectively, associated with Graphite Bio, Inc., which later merged with LENZ Therapeutics, Inc. in March 2024, for which the lease terms were modified to accelerate expiration of the lease to December 2024. Termination fee income is included in rental and related revenues on the Consolidated Statements of Operations.

    (4)

    The three and six months ended June 30, 2024 and 2023 includes reserves and (recoveries) for expected loan losses recognized in impairments and loan loss reserves (recoveries), net in the Consolidated Statements of Operations.

    (5)

    Casualty-related charges (recoveries), net are recognized in other income (expense), net and equity income (loss) from unconsolidated joint ventures in the Consolidated Statements of Operations.

    Healthpeak Properties, Inc.

    Adjusted Funds From Operations

    In thousands, except per share data

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

    2024

     

    2023

     

    2024

     

    2023

    FFO as Adjusted applicable to common shares

    $

    315,639

     

     

    $

    249,202

     

     

    $

    590,919

     

     

    $

    478,741

     

    Stock-based compensation amortization expense

     

    4,814

     

     

     

    4,245

     

     

     

    8,180

     

     

     

    7,532

     

    Amortization of deferred financing costs and debt discounts (premiums)

     

    7,317

     

     

     

    2,954

     

     

     

    11,840

     

     

     

    5,774

     

    Straight-line rents(1)

     

    (10,453

    )

     

     

    (4,683

    )

     

     

    (22,545

    )

     

     

    (5,431

    )

    AFFO capital expenditures

     

    (35,718

    )

     

     

    (19,444

    )

     

     

    (53,235

    )

     

     

    (42,233

    )

    Deferred income taxes

     

    1,021

     

     

     

    (242

    )

     

     

    1,745

     

     

     

    (503

    )

    Amortization of above (below) market lease intangibles, net

     

    (8,086

    )

     

     

    (8,838

    )

     

     

    (15,437

    )

     

     

    (14,641

    )

    Other AFFO adjustments

     

    (2,169

    )

     

     

    (2,339

    )

     

     

    (3,667

    )

     

     

    (730

    )

    AFFO applicable to common shares

     

    272,365

     

     

     

    220,855

     

     

     

    517,800

     

     

     

    428,509

     

    Distributions on dilutive convertible units and other

     

    4,582

     

     

     

    2,342

     

     

     

    6,799

     

     

     

    4,686

     

    Diluted AFFO applicable to common shares

    $

    276,947

     

     

    $

    223,197

     

     

    $

    524,599

     

     

    $

    433,195

     

    Diluted AFFO per common share

    $

    0.39

     

     

    $

    0.40

     

     

    $

    0.79

     

     

    $

    0.78

     

    Weighted average shares outstanding - Diluted AFFO

     

    717,797

     

     

     

    554,584

     

     

     

    663,975

     

     

     

    554,494

     

    _______________________________________

    (1)

    The six months ended June 30, 2023 includes an $8.7 million write-off of straight-line rent receivable associated with Sorrento Therapeutics, Inc., which commenced voluntary reorganization proceedings under Chapter 11 of the U.S. Bankruptcy Code. This activity is reflected as a reduction of rental and related revenues in the Consolidated Statements of Operations.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240725559703/en/

    Get the next $DOC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DOC

    DatePrice TargetRatingAnalyst
    1/15/2025$25.00Equal-Weight → Overweight
    Morgan Stanley
    10/21/2024$20.00 → $28.00Hold → Buy
    Deutsche Bank
    5/3/2024Neutral → Outperform
    Wedbush
    4/26/2024$19.00 → $21.00Neutral → Outperform
    Exane BNP Paribas
    4/22/2024$22.00Buy
    Mizuho
    4/1/2024$18.00 → $25.00Underperform → Buy
    BofA Securities
    3/25/2024$19.00Equal Weight
    Wells Fargo
    3/8/2024$21.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $DOC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Healthpeak Properties Reports First Quarter 2025 Results

      Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the first quarter ended March 31, 2025. FIRST QUARTER 2025 FINANCIAL PERFORMANCE AND RECENT HIGHLIGHTS Net income of $0.06 per share, Nareit FFO of $0.45 per share, FFO as Adjusted of $0.46 per share, AFFO of $0.43 per share, and Total Same-Store Portfolio Cash (Adjusted) NOI growth of 7.0% On April 4, 2025, declared a monthly common stock cash dividend of $0.10167 per share for each of April, May, and June of 2025 representing cash dividends of $0.305 per share for the second quarter, and an annualized dividend amount of $1.

      4/24/25 4:17:00 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • Healthpeak Properties Names Kelvin Moses as Chief Financial Officer

      Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced that current Executive Vice President – Investments and Portfolio Management, Kelvin Moses, has been promoted and appointed as its Chief Financial Officer. "Kelvin has made a tremendous impact since joining Healthpeak in 2018, and we are excited to elevate him to this key role on the executive team," said Scott Brinker, President and Chief Executive Officer. "His strategic mindset, healthcare insight, and investment and operational experience make him uniquely qualified to help guide Healthpeak through our next phase of growth. I have full confide

      4/24/25 4:15:00 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Second Quarter of 2025

      Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced that on April 4, 2025, its Board of Directors declared a monthly common stock cash dividend of $0.10167 per share for the second quarter of 2025, payable on the payment dates set forth in the table below to stockholders of record as of the close of business on the corresponding record date in the table below. The monthly dividend reflects an annualized dividend amount of $1.22 per share of common stock. Record Date Payment Date Amount April 18, 2025 April 30, 2025 $0.10167 per common share May 19, 2025 May 30, 2025 $0

      4/7/25 4:15:00 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate

    $DOC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Healthpeak Properties upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded Healthpeak Properties from Equal-Weight to Overweight and set a new price target of $25.00

      1/15/25 7:33:36 AM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • Healthpeak Properties upgraded by Deutsche Bank with a new price target

      Deutsche Bank upgraded Healthpeak Properties from Hold to Buy and set a new price target of $28.00 from $20.00 previously

      10/21/24 7:38:33 AM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • Healthpeak Properties upgraded by Wedbush

      Wedbush upgraded Healthpeak Properties from Neutral to Outperform

      5/3/24 7:31:37 AM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate

    $DOC
    SEC Filings

    See more
    • Healthpeak Properties Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - HEALTHPEAK PROPERTIES, INC. (0000765880) (Filer)

      5/12/25 4:15:58 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • SEC Form S-8 filed by Healthpeak Properties Inc.

      S-8 - HEALTHPEAK PROPERTIES, INC. (0000765880) (Filer)

      4/28/25 4:57:21 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • Healthpeak Properties Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - HEALTHPEAK PROPERTIES, INC. (0000765880) (Filer)

      4/28/25 4:15:29 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate

    $DOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Thompson Tommy G bought $99,769 worth of shares (5,777 units at $17.27), increasing direct ownership by 4% to 144,290 units (SEC Form 4)

      4 - HEALTHPEAK PROPERTIES, INC. (0000765880) (Issuer)

      5/28/25 1:15:22 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • Director Thompson Tommy G bought $98,974 worth of shares (5,700 units at $17.36), increasing direct ownership by 4% to 138,513 units (SEC Form 4)

      4 - HEALTHPEAK PROPERTIES, INC. (0000765880) (Issuer)

      5/12/25 12:02:07 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • President and CEO Brinker Scott M bought $47,822 worth of shares (2,750 units at $17.39), increasing direct ownership by 1% to 204,613 units (SEC Form 4)

      4 - HEALTHPEAK PROPERTIES, INC. (0000765880) (Issuer)

      5/12/25 12:01:36 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate

    $DOC
    Financials

    Live finance-specific insights

    See more
    • Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Second Quarter of 2025

      Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced that on April 4, 2025, its Board of Directors declared a monthly common stock cash dividend of $0.10167 per share for the second quarter of 2025, payable on the payment dates set forth in the table below to stockholders of record as of the close of business on the corresponding record date in the table below. The monthly dividend reflects an annualized dividend amount of $1.22 per share of common stock. Record Date Payment Date Amount April 18, 2025 April 30, 2025 $0.10167 per common share May 19, 2025 May 30, 2025 $0

      4/7/25 4:15:00 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • Healthpeak Properties Announces First Quarter 2025 Earnings Release Date and Conference Call Details

      Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report first quarter 2025 financial results after the close of trading on the New York Stock Exchange on Thursday, April 24, 2025. Healthpeak will host a conference call and webcast on Friday, April 25, 2025, at 8:00 a.m. Mountain Time (10:00 a.m. Eastern Time) to review its financial performance and operating results. The conference call can be accessed in the following ways: Healthpeak's website: https://ir.healthpeak.com/news-events Webcast: https://events.q4inc.com/attendee/794734425. Joining via webcast is recommended for those who

      4/3/25 4:15:00 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • Land & Buildings Nominates Two Independent Candidates – Jim Hoffmann and Adam Troso – for Board of National Health Investors

      Believes That Incremental Changes Since Last Annual Meeting Are Insufficient to Address the Poor Corporate Governance and Concerning Conflicts of Interest Threatening to Prevent NHI From Reaching its Full Value Potential Highlights the Urgent Need for NHI to Have Truly Independent Directors With the Right Expertise in the Boardroom Given Ongoing Lease Renewal Negotiations With Major Tenant National Healthcare Corp (NHC) Details Concerns That NHC Lease Negotiations Will Not Reflect Market Value Given Board Member Conflicts; Lease Likely Has 75% Upside Based on Strong Coverage and Precedent Transactions and Could Boost Earnings 13% Or More Believes NHI Shares Have 50% Upside Over the Next

      2/19/25 8:00:00 AM ET
      $DOC
      $GHL
      $HCP
      $ING
      Real Estate Investment Trusts
      Real Estate
      Investment Bankers/Brokers/Service
      Finance

    $DOC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Healthpeak Properties Inc.

      SC 13G/A - HEALTHPEAK PROPERTIES, INC. (0000765880) (Subject)

      10/23/24 5:04:46 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G filed by Healthpeak Properties Inc.

      SC 13G - Physicians Realty Trust (0001574540) (Subject)

      3/8/24 4:20:35 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Healthpeak Properties Inc. (Amendment)

      SC 13G/A - Physicians Realty Trust (0001574540) (Subject)

      3/7/24 12:29:51 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate

    $DOC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Thompson Tommy G bought $99,769 worth of shares (5,777 units at $17.27), increasing direct ownership by 4% to 144,290 units (SEC Form 4)

      4 - HEALTHPEAK PROPERTIES, INC. (0000765880) (Issuer)

      5/28/25 1:15:22 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • Director Thompson Tommy G bought $98,974 worth of shares (5,700 units at $17.36), increasing direct ownership by 4% to 138,513 units (SEC Form 4)

      4 - HEALTHPEAK PROPERTIES, INC. (0000765880) (Issuer)

      5/12/25 12:02:07 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • President and CEO Brinker Scott M bought $47,822 worth of shares (2,750 units at $17.39), increasing direct ownership by 1% to 204,613 units (SEC Form 4)

      4 - HEALTHPEAK PROPERTIES, INC. (0000765880) (Issuer)

      5/12/25 12:01:36 PM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate

    $DOC
    Leadership Updates

    Live Leadership Updates

    See more
    • American Homes 4 Rent Set to Join S&P MidCap 400

      NEW YORK, Feb. 26, 2024 /PRNewswire/ -- American Homes 4 Rent (NYSE:AMH) will replace Physicians Realty Trust (NYSE:DOC) in the S&P MidCap 400 effective prior to the opening of trading on Friday, March 1. S&P 500 constituent Healthpeak Properties Inc. (NYSE:PEAK) is acquiring Physicians Realty Trust in a deal expected to be completed soon pending final conditions. Post-merger, Healthpeak Properties will have a symbol change from PEAK to DOC. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector March 1, 2024 S&P MidCap 400 Addition American Homes 4 Rent AMH Real E

      2/26/24 6:04:00 PM ET
      $AMH
      $DOC
      $PEAK
      $SPGI
      Real Estate Investment Trusts
      Real Estate
      Finance: Consumer Services
      Finance